Envoy Medical Announces Third Quarter 2026 Financial Results Date
Envoy Medical, Inc. has scheduled the release of its financial results for the third quarter ended September 30, 2026, for November 5, 2026.
Stocks · News reference
Envoy Medical Reaches Six-Month Milestone in Acclaim Cochlear Implant Pivotal Trial
Envoy Medical has surpassed the six-month follow-up visit milestone for its pivotal clinical trial of the investigational Acclaim cochlear implant, marking the halfway point in the study's final data collection stage.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Envoy Medical Announces Reverse Stock Split
Envoy Medical, Inc. has announced a reverse stock split of its common stock.
Envoy Medical Surpasses 6-Month Follow-Up Visit Milestone For Pivotal Clinical Trial Evaluating Investigational Fully Implanted Acclaim Cochlear Implant; Expects To Submit Final Clinical PMA Module By End Of Q2 2027
Company Believes It Is the First to Reach This Milestone in a U.S. Pivotal Trial of a Fully Implanted Cochlear ImplantRemains on Track to Reach 12-Month Visit Milestone by Early Q2 2027 and Submit Final Clinical PMA